Eur Rev Med Pharmacol Sci 2020; 24 (22): 11469-11469
DOI: 10.26355/eurrev_202011_23761

MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B

R. Ren, J. Wu, M.-Y. Zhou

Department of Gynaecology, Gansu Provincial Hospital, Lanzhou, China.

The article “MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B, by R. Ren, J. Wu, M.-Y. Zhou, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3548-3554–DOI: 10.26355/eurrev_202004_20815–PMID: 32329828” has been withdrawn from the authors stating that “some data cannot be repeated by our further research”.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/20815

Free PDF Download

To cite this article

R. Ren, J. Wu, M.-Y. Zhou
MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11469-11469
DOI: 10.26355/eurrev_202011_23761

Keywords Related articles:

  1. MiR-135b-5p affected malignant behaviors of ovarian cancer cells by targeting KDM5B
  2. MiR-135b-5p inhibits the progression of malignant melanoma cells by targeting RBX1
  3. MiR-34a-5p directly targeting TRIM44 affects the biological behavior of ovarian cancer cells
  4. Overexpression of miR-32 inhibits the proliferation and metastasis of ovarian cancer cells by targeting BTLA
  5. MiR-4429 suppresses the malignant development of ovarian cancer by targeting YOD1